Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Certain Dibenzo derivatives may help treat prostate cancer.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

A synthetic octapeptide may help promote hair growth and counteract hair loss.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Trazodone might help reverse post finasteride syndrome.

Exercise is crucial for managing polycystic ovary syndrome (PCOS) and improving overall health.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Hormone testing may not be very helpful in diagnosing female pattern hair loss.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Exosomes from stem cells help hair regrowth by activating a specific signaling pathway.